Reserved for Seroba Lifesciences

50% off the $29 audit or $99 Fix-It Kit. Use at checkout:

SEROBALIFESC50

⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

Seroba Lifesciences

Seroba Lifesciences

Unclaimed

AEO Score: 4/10

Crawled 1 times by AI engines

Claude

seroba-lifesciences.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Seroba Lifesciences just got measured.

4/10 means Seroba Lifesciences is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About Seroba Lifesciences

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Key Topics

Homepage
The Millipede88® is the first 088 aspiration catheter with patented corrugated technology cleared for standalone direct aspiration – no large-bore intermediary required- backed by independently adjudicated MARRS study data showing a 77% first-pass effect1 in M1 occlusions and 96% delivery success. Perfuze, a medical device company dedicated to advancing stroke treatment through next-generation catheter technology, today announced it has received …
Europe is a science powerhouse, but can it also lead in biotech and healthcare innovation? That’s the pressing question at the heart of Invest Europe’s  latest position paper:  “Biotech and Healthcare: The Venture Capital and Private Equity Perspective.” Seroba and BGV are proud to have led, along with Hadean, the development of Invest Europe’s position paper, refined and adopted through …
Complement Therapeutics GmbH (CTx), a biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for CTx001, the company’s lead gene therapy candidate. The IND clearance enables initiation of the Opti-GAIN Phase I/II clinical trial in patients with Geographic Atrophy (GA) secondary to Age-related …

Details

Industry: Technology

seroba-lifesciences.com

AI Visibility Breakdown

2

Structured Data

6

Content Structure

5

Entity Clarity

2

E-E-A-T Signals

6

Technical AEO

3

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for Seroba Lifesciences: Tech & Electronics

Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?

Tech buyers are the most research-intensive shoppers on the internet.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Seroba Lifesciences.

Source & Attribution

Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/seroba-lifesciences

Cite this score: Engagemii (2026). "AEO Score for Seroba Lifesciences." Retrieved from https://engagemii.com/aeo/brands/seroba-lifesciences

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform